Letter Published: 09 February 1957 5-Hydroxytryptamine in Acute Inflammation W. G. SPECTOR & D. A. WILLOUGHBY Nature 179, 318 (1957) Cite this article ...

5-Hydroxytryptamine produces reversible aggregation of human blood platelets and potentiates aggregation brought about by adrenaline and ADP. Within a wide range, these effects are inhibited in ...

5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) pipeline Target constitutes close to 10 molecules. Out of which approximately 9 molecules are developed by companies and ...

5-Hydroxytryptamine-3 Receptor Antagonist With or Without Short-Course Dexamethasone in the Prophylaxis of Radiation Induced Emesis: A Placebo-Controlled Randomized Trial of the National Cancer ...

PURPOSE: To compare the effect of 5-hydroxytryptamine-3 (5HT3) receptor antagonists in cancer patients receiving chemotherapy including cisplatin (CDDP), with or without sustained-release oral ...